Apollo Hospitals Enterprise Limited has scheduled meetings of its equity shareholders, secured creditors, and unsecured creditors on June 24, 2026, pursuant to orders from the National Company Law Tribunal (NCLT), Chennai Bench. The meetings, convened to seek approval for a composite scheme of arrangement, will be held through video conferencing and other audio-visual means (VC/OAVM). The scheme involves the demerger of a business undertaking into Apollo Healthtech Limited and the amalgamation of Apollo Healthco Limited and Keimed Private Limited with the resultant company.

The primary agenda is the approval of the composite scheme aimed at streamlining operations by carving out distinct business verticals into focused entities. The scheme has received necessary no-objection letters from BSE Limited and the National Stock Exchange of India Limited (NSE) and approval from the Competition Commission of India (CCI). The resultant company will be listed on the stock exchanges upon the scheme's effectiveness.

Meeting and Voting Details

The meetings for different classes of stakeholders are scheduled at specific times on June 24, 2026. Shareholders and creditors whose names appear in the register of members or beneficial owners as on the respective cut-off dates are entitled to attend and vote. The company has appointed National Securities Depository Limited (NSDL) to facilitate the voting process and the virtual meetings.

Remote e-voting for all eligible stakeholders will commence on June 20, 2026, at 9:00 AM (IST) and conclude on June 23, 2026, at 5:00 PM (IST). The cut-off date for determining the eligibility of equity shareholders for voting is June 17, 2026. For secured and unsecured creditors, the cut-off date is December 31, 2025.

Scheme Structure and Approvals

The composite scheme provides for the issuance of fully paid-up equity shares of the Resultant Company to eligible shareholders of the Demerged Company and the transferor companies based on specific entitlement ratios. The authorized and paid-up share capital of the involved entities will undergo changes to accommodate the issuance of shares and the cancellation of capital in the transferor companies upon the scheme's effectiveness.

NCLT has appointed Dr. K. S. Ravichandran, PCS, Managing Partner of KSR & Co., Company Secretaries LLP, as the Chairperson for the meetings. Mr. S. Vedhavel, Advocate, has been appointed as the Scrutinizer to conduct the remote e-voting process. The scheme, if approved, will be subject to the subsequent sanction of the NCLT.

Apollo Hospitals Enterprise Limited has announced its financial results for the quarter and year ended March 31, 2026, reporting strong growth across key metrics. The company reported consolidated revenue of ₹66,055 million for Q4 FY26, compared to ₹55,900 million in the same period last year, reflecting an 18% year-over-year increase. Consolidated Profit After Tax (PAT) for the quarter stood at ₹5,292 million, up from ₹3,900 million in the prior year period, growing by 36% year-over-year. The transcript of the earnings call presentation held on May 21, 2026, is now available on the company's website.

Consolidated Financial Performance

The company's EBITDA for the quarter grew by 31% to ₹10,100 million, compared to ₹7,700 million in the year-ago period, while the EBITDA margin expanded to 15.31% from 13.76% year-over-year. The growth was driven by strong performance across its Healthcare Services, Diagnostics & Retail Health, and Digital Health & Pharmacy Distribution segments.

Segment Performance

Healthcare Services revenue grew by 16% to ₹32,678 million, with an EBITDA of ₹7,806 million. Apollo Health & Lifestyle Ltd (AHLL) reported a 24% increase in revenue to ₹4,895 million, driven by a 52% growth in Diagnostics. Apollo HealthCo's revenue rose by 20% to ₹28,482 million, with the segment achieving a PAT of ₹1,076 million, a significant increase compared to the previous year.

Strategic Transactions

The Board approved a transaction involving Apollo Health and Lifestyle Limited (AHLL) and Kids Clinic India Limited (Cloudnine). As part of the deal, Apollo Hospitals has merged its Cradle business with Cloudnine at a 35X EBITDA multiple. AHLL will divest its stake in Apollo Specialty Hospitals Private Limited and Apollo Fertility Centre Private Limited to Kids Clinic India Limited at an enterprise value of approximately ₹15,500 million. The consideration includes ₹7,650 million in cash and an equity stake of approximately 9.9% in Kids Clinic India Limited, along with a board seat.